---
$id: https://graph.org.ai/products/commodity/51151549
$type: Product
source: UNSPSC
code: "51151549"
title: "Rivastigmine hydrogen tartrate"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rivastigmine hydrogen tartrate

**UNSPSC Code**: 51151549
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C14H22N2O2.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9IY2357JPE, chemically known as 2,6-dioxo-4-phenyl-piperidine-3-carbonitrile but more generally known as rivastigmine hydrogen tartrate, which bears US NIH Compound Identifier 77991. European Medicines Agency schedules Rivastigmine hydrogen tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04257MIG. Most nations, for tariff and trade purposes, schedule rivastigmine hydrogen tartrate under HS 29242995 and SITC 51479. SMILES: CCN(C)C(=O)OC1CCCC(C1)[C@H](C)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

